NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2045831674|ref|NP_689787|]
View 

tetratricopeptide repeat protein 39B isoform 1 [Homo sapiens]

Protein Classification

tetratricopeptide repeat protein 39( domain architecture ID 12104540)

tetratricopeptide repeat (TPR) protein 39 such as human TTC39B, which promotes the ubiquitination and degradation of liver X receptor

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Iml2-TPR_39 pfam10300
Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to ...
76-532 0e+00

Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to humans, including fungal Inclusion body clearance protein Iml2 protein, animal tetratricopeptide repeat protein 39A/B/C (TT39A/B/C) and some uncharacterized proteins. Members of this family carry a tetratricopeptide repeat pfam07719 at their C terminus. This entry includes Iml2 and its paralogue-YKR018C from S. cerevisiae; Iml2 localizes to the cytoplasm and nucleus, and its expression is increased in response to DNA replication stress. It is found to be involved in lipid droplet-mediated inclusion body clearing after protein folding stress. In humans, TTC39A (also known as DEME6) is expressed in primary breast carcinomas but not in normal breast tissue, and has a putative eukaryotic RNP-1 RNA binding region and a candidate anchoring transmembrane domain. It is coordinately regulated with oestrogen receptor, but is not necessarily oestradiol-responsive. TTC39B has been linked to lipid metabolism.


:

Pssm-ID: 463047 [Multi-domain]  Cd Length: 469  Bit Score: 625.53  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674  76 ALNLFLSNKFTDALELLRPWAKESMYHALGYSTIVVLQAVLTFEQQDIQNGISAMKDALQTCQKYRKKYTVVESFSSLls 155
Cdd:pfam10300   3 ALDLFLNNKFEEALELLKPWSKNSMYHALGYSVVAFIQAMLTFEPEDIQQASEALKEAEQVCQRFRKKAQVNESIQNT-- 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 156 rgSLEQLSEEEMHAEICYAECLLQKAALTFvQDENMINFIKGGLKIRTSYQIYKECLSILHEIQK--------------N 221
Cdd:pfam10300  81 --DTSQLYEPGTHAEVCYAECLLLKAALTF-QDESLVSFIKGGYKLRKAYQIYKECLKLINDPQQtkrsspgdsslshnD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 222 KLQQEFFYEFEGGVKLGSGAFNLMLSLLPARIIRLLEFIGFSGNRELGLLQLREGASGRSMRSALCCLTILAFHTYISLI 301
Cdd:pfam10300 158 NNQAEIDEFFESGVNLGFGIFNLMLSLLPPRILKLLEFIGFSGDREDGLRLLWEASKSPNIRAALALLTLLFYYTGVRQV 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 302 LGT--GEVNVAEAERLLAPFLQQFPNGSLVLFYHARIELLKGNLEEAQEVFQKCISVQEEWKQFHHLCYWELMWINVFQQ 379
Cdd:pfam10300 238 LGIpgGEGPLEEAEALLLPYRKRYPNGALWLFFEARIESLKGNLDEALELFEECIESQSEWKQVHHLCYWELMWCLVFLH 317
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 380 NWMQAYYYSDLLCKESKWSKATYVFLKAAILSMLPEEDVVATN-ENVVTLFRQVDSLKQRIAGKSIPTEKFAVRKARRYS 458
Cdd:pfam10300 318 NWKQAANYFLLLVKESSWSHALYTYFAAACLLMLYREEEAPAAkERAVELFREVPTLKQKIAGKSLPLEKFAARKVQRFK 397
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2045831674 459 ASLPAPVKLILPALEMMYVWNGFSIVSKRKDLSENLLVTVEKAEAAlqSQNFNSFSVDDECLVKLLKGCCLKNL 532
Cdd:pfam10300 398 ARTPADAVLVSPLLELIYFWNGFSRMGKKPLLTESVLKLIEKALKA--NPTSEAQEPDDKCLKQLLKGLCLRHL 469
TPR_12 pfam13424
Tetratricopeptide repeat;
528-592 2.78e-03

Tetratricopeptide repeat;


:

Pssm-ID: 315987 [Multi-domain]  Cd Length: 77  Bit Score: 36.98  E-value: 2.78e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2045831674 528 CLKNLQRPLQAELCYNHVVE-SEKLLKYDHYLVPFTLFELASLYKSQGEIDKAIKFLETARNNYKD 592
Cdd:pfam13424  12 VLRRLGRYDEALELLEKALEiARRLLGPDHPLTATTLLNLGRLYLELGRYEEALELLERALALAEK 77
 
Name Accession Description Interval E-value
Iml2-TPR_39 pfam10300
Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to ...
76-532 0e+00

Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to humans, including fungal Inclusion body clearance protein Iml2 protein, animal tetratricopeptide repeat protein 39A/B/C (TT39A/B/C) and some uncharacterized proteins. Members of this family carry a tetratricopeptide repeat pfam07719 at their C terminus. This entry includes Iml2 and its paralogue-YKR018C from S. cerevisiae; Iml2 localizes to the cytoplasm and nucleus, and its expression is increased in response to DNA replication stress. It is found to be involved in lipid droplet-mediated inclusion body clearing after protein folding stress. In humans, TTC39A (also known as DEME6) is expressed in primary breast carcinomas but not in normal breast tissue, and has a putative eukaryotic RNP-1 RNA binding region and a candidate anchoring transmembrane domain. It is coordinately regulated with oestrogen receptor, but is not necessarily oestradiol-responsive. TTC39B has been linked to lipid metabolism.


Pssm-ID: 463047 [Multi-domain]  Cd Length: 469  Bit Score: 625.53  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674  76 ALNLFLSNKFTDALELLRPWAKESMYHALGYSTIVVLQAVLTFEQQDIQNGISAMKDALQTCQKYRKKYTVVESFSSLls 155
Cdd:pfam10300   3 ALDLFLNNKFEEALELLKPWSKNSMYHALGYSVVAFIQAMLTFEPEDIQQASEALKEAEQVCQRFRKKAQVNESIQNT-- 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 156 rgSLEQLSEEEMHAEICYAECLLQKAALTFvQDENMINFIKGGLKIRTSYQIYKECLSILHEIQK--------------N 221
Cdd:pfam10300  81 --DTSQLYEPGTHAEVCYAECLLLKAALTF-QDESLVSFIKGGYKLRKAYQIYKECLKLINDPQQtkrsspgdsslshnD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 222 KLQQEFFYEFEGGVKLGSGAFNLMLSLLPARIIRLLEFIGFSGNRELGLLQLREGASGRSMRSALCCLTILAFHTYISLI 301
Cdd:pfam10300 158 NNQAEIDEFFESGVNLGFGIFNLMLSLLPPRILKLLEFIGFSGDREDGLRLLWEASKSPNIRAALALLTLLFYYTGVRQV 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 302 LGT--GEVNVAEAERLLAPFLQQFPNGSLVLFYHARIELLKGNLEEAQEVFQKCISVQEEWKQFHHLCYWELMWINVFQQ 379
Cdd:pfam10300 238 LGIpgGEGPLEEAEALLLPYRKRYPNGALWLFFEARIESLKGNLDEALELFEECIESQSEWKQVHHLCYWELMWCLVFLH 317
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 380 NWMQAYYYSDLLCKESKWSKATYVFLKAAILSMLPEEDVVATN-ENVVTLFRQVDSLKQRIAGKSIPTEKFAVRKARRYS 458
Cdd:pfam10300 318 NWKQAANYFLLLVKESSWSHALYTYFAAACLLMLYREEEAPAAkERAVELFREVPTLKQKIAGKSLPLEKFAARKVQRFK 397
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2045831674 459 ASLPAPVKLILPALEMMYVWNGFSIVSKRKDLSENLLVTVEKAEAAlqSQNFNSFSVDDECLVKLLKGCCLKNL 532
Cdd:pfam10300 398 ARTPADAVLVSPLLELIYFWNGFSRMGKKPLLTESVLKLIEKALKA--NPTSEAQEPDDKCLKQLLKGLCLRHL 469
TPR_12 pfam13424
Tetratricopeptide repeat;
528-592 2.78e-03

Tetratricopeptide repeat;


Pssm-ID: 315987 [Multi-domain]  Cd Length: 77  Bit Score: 36.98  E-value: 2.78e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2045831674 528 CLKNLQRPLQAELCYNHVVE-SEKLLKYDHYLVPFTLFELASLYKSQGEIDKAIKFLETARNNYKD 592
Cdd:pfam13424  12 VLRRLGRYDEALELLEKALEiARRLLGPDHPLTATTLLNLGRLYLELGRYEEALELLERALALAEK 77
 
Name Accession Description Interval E-value
Iml2-TPR_39 pfam10300
Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to ...
76-532 0e+00

Iml2/Tetratricopeptide repeat protein 39; This is a family of proteins conserved from fungi to humans, including fungal Inclusion body clearance protein Iml2 protein, animal tetratricopeptide repeat protein 39A/B/C (TT39A/B/C) and some uncharacterized proteins. Members of this family carry a tetratricopeptide repeat pfam07719 at their C terminus. This entry includes Iml2 and its paralogue-YKR018C from S. cerevisiae; Iml2 localizes to the cytoplasm and nucleus, and its expression is increased in response to DNA replication stress. It is found to be involved in lipid droplet-mediated inclusion body clearing after protein folding stress. In humans, TTC39A (also known as DEME6) is expressed in primary breast carcinomas but not in normal breast tissue, and has a putative eukaryotic RNP-1 RNA binding region and a candidate anchoring transmembrane domain. It is coordinately regulated with oestrogen receptor, but is not necessarily oestradiol-responsive. TTC39B has been linked to lipid metabolism.


Pssm-ID: 463047 [Multi-domain]  Cd Length: 469  Bit Score: 625.53  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674  76 ALNLFLSNKFTDALELLRPWAKESMYHALGYSTIVVLQAVLTFEQQDIQNGISAMKDALQTCQKYRKKYTVVESFSSLls 155
Cdd:pfam10300   3 ALDLFLNNKFEEALELLKPWSKNSMYHALGYSVVAFIQAMLTFEPEDIQQASEALKEAEQVCQRFRKKAQVNESIQNT-- 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 156 rgSLEQLSEEEMHAEICYAECLLQKAALTFvQDENMINFIKGGLKIRTSYQIYKECLSILHEIQK--------------N 221
Cdd:pfam10300  81 --DTSQLYEPGTHAEVCYAECLLLKAALTF-QDESLVSFIKGGYKLRKAYQIYKECLKLINDPQQtkrsspgdsslshnD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 222 KLQQEFFYEFEGGVKLGSGAFNLMLSLLPARIIRLLEFIGFSGNRELGLLQLREGASGRSMRSALCCLTILAFHTYISLI 301
Cdd:pfam10300 158 NNQAEIDEFFESGVNLGFGIFNLMLSLLPPRILKLLEFIGFSGDREDGLRLLWEASKSPNIRAALALLTLLFYYTGVRQV 237
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 302 LGT--GEVNVAEAERLLAPFLQQFPNGSLVLFYHARIELLKGNLEEAQEVFQKCISVQEEWKQFHHLCYWELMWINVFQQ 379
Cdd:pfam10300 238 LGIpgGEGPLEEAEALLLPYRKRYPNGALWLFFEARIESLKGNLDEALELFEECIESQSEWKQVHHLCYWELMWCLVFLH 317
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2045831674 380 NWMQAYYYSDLLCKESKWSKATYVFLKAAILSMLPEEDVVATN-ENVVTLFRQVDSLKQRIAGKSIPTEKFAVRKARRYS 458
Cdd:pfam10300 318 NWKQAANYFLLLVKESSWSHALYTYFAAACLLMLYREEEAPAAkERAVELFREVPTLKQKIAGKSLPLEKFAARKVQRFK 397
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2045831674 459 ASLPAPVKLILPALEMMYVWNGFSIVSKRKDLSENLLVTVEKAEAAlqSQNFNSFSVDDECLVKLLKGCCLKNL 532
Cdd:pfam10300 398 ARTPADAVLVSPLLELIYFWNGFSRMGKKPLLTESVLKLIEKALKA--NPTSEAQEPDDKCLKQLLKGLCLRHL 469
TPR_12 pfam13424
Tetratricopeptide repeat;
528-592 2.78e-03

Tetratricopeptide repeat;


Pssm-ID: 315987 [Multi-domain]  Cd Length: 77  Bit Score: 36.98  E-value: 2.78e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2045831674 528 CLKNLQRPLQAELCYNHVVE-SEKLLKYDHYLVPFTLFELASLYKSQGEIDKAIKFLETARNNYKD 592
Cdd:pfam13424  12 VLRRLGRYDEALELLEKALEiARRLLGPDHPLTATTLLNLGRLYLELGRYEEALELLERALALAEK 77
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH